Regulation of the wild-type and Y1235D mutant Met kinase activation.

Regulation of the wild-type and Y1235D mutant Met kinase activation.

Met receptor tyrosine kinase plays a crucial role in the regulation of a large number of cellular processes and, when deregulated by overexpression or mutations, leads to tumor growth and invasion. The Y1235D mutation identified in metastases was shown to induce constitutive activation and a motile-...

書誌詳細
主要な著者:	Cristiani, C, Rusconi, L, Perego, R, Schiering, N, Kalisz, H, Knapp, S, Isacchi, A
フォーマット:	Journal article
言語:	English
出版事項:	2005

類似資料

Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a.
著者:: Schiering, N, 等
出版事項: (2003)

Clinical significance of c-Met and phospho-c-Met (Tyr1234/1235) in ovarian cancer
著者:: Ling Lim, 等
出版事項: (2019-01-01)

Rescue of NBD2 mutants N1303K and S1235R of CFTR by small-molecule correctors and transcomplementation.
著者:: Daniele Rapino, 等
出版事項: (2015-01-01)

Kurultai of 1235: Question of Expansion of the Ulus of Jochi »
著者:: I.М. Mirgaleev
出版事項: (2014-09-01)

Activation of Zap-70 tyrosine kinase due to a structural rearrangement induced by tyrosine phosphorylation and/or ITAM binding.
著者:: Visco, C, 等
出版事項: (2000)

P1235: INVESTIGATION OF THE CO-MUTATIONAL LANDSCAPE OF ALK-POSITIVE ALCL
著者:: Matteo Villa, 等
出版事項: (2023-08-01)

Early Hungarian Information about the Mongol Western Campaign (1235–1242) »
著者:: Roman Hautala
出版事項: (2015-09-01)

1,2,3,5-Tetrahydronaphtho[2,1-c]oxepine
著者:: Alan J. Lough, 等
出版事項: (2020-03-01)

Preparation of 4-benzylsulfanyl[1,2,3,5]dithiadiazol-1-ylium chlorides: potential precursors to meso-ionic 1,2,3,5-dithiadiazolium-4-thiolate
著者:: Thomas Gelbrich, 等
出版事項: (2002-10-01)

Pirtobrutinib inhibits wild-type and mutant Bruton’s tyrosine kinase-mediated signaling in chronic lymphocytic leukemia
著者:: Burcu Aslan, 等
出版事項: (2022-05-01)

1235 Safety of Immune checkpoint inhibitors in elderly patients over 75 years
著者:: Muhammad Awidi, 等
出版事項: (2023-11-01)

Tau decay into $$\nu _\tau $$ ντ and $$a_1(1260)$$ a1(1260) , $$b_1(1235)$$ b1(1235) , and two $$K_1(1270)$$ K1(1270)
著者:: L. R. Dai, 等
出版事項: (2020-07-01)

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer
著者:: Zhe Zhang, 等
出版事項: (2019-11-01)

Proteome Regulation Patterns Determine Escherichia coli Wild-Type and Mutant Phenotypes
著者:: Tobias B. Alter, 等
出版事項: (2021-04-01)

Differential responses of MET activations to MET kinase inhibitor and neutralizing antibody
著者:: Jianqun Kou, 等
出版事項: (2018-09-01)

1,2,3,5-Tetramethyl-1H-pyrazol-2-ium triiodide
著者:: Stefan Oberparleiter, 等
出版事項: (2016-08-01)

Observing student´s syntactic errors and the perceptions towards writing in the composition course LM-1235
著者:: César Alberto Navas Brenes
出版事項: (2017-04-01)

History from Comic Hypotheses: Stratocles, Lachares, and <i>P.Oxy. 1235</i>
著者:: Lara O'Sullivan
出版事項: (2010-11-01)

In silico analysis of wild-type and mutant KRAS
著者:: Frengki Frengki, 等
出版事項: (2019-05-01)

Raoul de Houdenc et les routes noveles de la fiction 1200-1235
著者:: Fernando Carmona Fernández
出版事項: (2019-12-01)

Protein tyrosine phosphatase receptor type E (PTPRE) regulates the activation of wild-type KIT and KIT mutants differently
著者:: Shaoting Zhang, 等
出版事項: (2021-07-01)

Aurora kinase-C-T191D is constitutively active mutant
著者:: Khan Jabbar, 等
出版事項: (2012-03-01)

Unraveling the Role of TP53 in Colorectal Cancer Therapy: From Wild-Type Regulation to Mutant
著者:: Wenshu Li, 等
出版事項: (2024-07-01)

Redox Sensitive Cysteine Residues as Crucial Regulators of Wild-Type and Mutant p53 Isoforms
著者:: Elena Butturini, 等
出版事項: (2021-11-01)

Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors
著者:: Figeys Daniel, 等
出版事項: (2008-09-01)

Wild-Type IDH1 and Mutant IDH1 Opposingly Regulate Podoplanin Expression in Glioma
著者:: Chao Sun, 等
出版事項: (2020-04-01)

Vecabrutinib inhibits B-cell receptor signal transduction in chronic lymphocytic leukemia cell types with wild-type or mutant Bruton tyrosine kinase
著者:: Burcu Aslan, 等
出版事項: (2021-09-01)

Glucose Starvation Alters Heat Shock Response, Leading to Death of Wild Type Cells and Survival of MAP Kinase Signaling Mutant.
著者:: Nora Plesofsky, 等
出版事項: (2016-01-01)

Transformation of HepG2 nascent lipoproteins by LCAT: modulation by HepG2 d > 1.235 g/ml fraction.
著者:: MR McCall, 等
出版事項: (1993-01-01)

In silico analysis of the wild-type and mutant-type of BRCA2 gene
著者:: Jingjing Li, 等
出版事項: (2024-05-01)

The 4-(3-chloro-4-methylphenyl)-1,2,3,5-dithiadiazol-3-yl radical
著者:: Jacqueline M. Cole, 等
出版事項: (2011-09-01)

Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607
著者:: Dai Yao, 等
出版事項: (2012-05-01)

Metabolomics of 293T IDH1 mutant and wild-type cells
著者:: Walsby-Tickle, J
出版事項: (2020)

Normalization of NPM1 mutant transcript to the wild‐type transcript
著者:: Lawrence J. Jennings
出版事項: (2022-11-01)

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability
著者:: YiQing Lü, 等
出版事項: (2024-04-01)

Retraction: Aurora kinase-C-T191D is constitutively active mutant
著者:: Khan Jabbar, 等
出版事項: (2012-06-01)

Antitumor imidazotetrazines. 38. New 8-substituted derivatives of the imidazo[5,1-d]-1,2,3,5-tetrazines temozolomide and mitozolomide
著者:: David A. F. Langnel, 等
出版事項: (2000-08-01)

N-Benzyl-6-deoxy-3,6-iminomethylene-1,2,3,5-O-tetraacetyl-&#945;-d-1(S)-epiallofuranose
著者:: Qiurong Zhang, 等
出版事項: (2011-06-01)

In vitro effectiveness of CB469, a MET tyrosine kinase inhibitor in MET-activated cancer cells
著者:: Ji Yeon Song, 等
出版事項: (2024-11-01)

Molecular Dynamics and Optimization Studies of Horse Prion Protein Wild Type and Its S167D Mutant
著者:: Jiapu Zhang
出版事項: (2024-08-01)